These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28459045)

  • 1. Re-Engineering Alzheimer Clinical Trials: Global Alzheimer's Platform Network.
    Cummings J; Aisen P; Barton R; Bork J; Doody R; Dwyer J; Egan JC; Feldman H; Lappin D; Truyen L; Salloway S; Sperling R; Vradenburg G
    J Prev Alzheimers Dis; 2016 Jun; 3(2):114-120. PubMed ID: 28459045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia.
    Saunders S; Gregory S; Clement MHS; Birck C; van der Geyten S; Ritchie CW
    Front Neurol; 2022; 13():1051543. PubMed ID: 36484017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0.
    Ritchie CW; Muniz-Terrera G; Kivipelto M; Solomon A; Tom B; Molinuevo JL
    J Prev Alzheimers Dis; 2020; 7(1):8-13. PubMed ID: 32010920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force.
    Aisen P; Touchon J; Andrieu S; Boada M; Doody R; Nosheny RL; Langbaum JB; Schneider L; Hendrix S; Wilcock G; Molinuevo JL; Ritchie C; Ousset PJ; Cummings J; Sperling R; DeKosky ST; Lovestone S; Hampel H; Petersen R; Legrand V; Egan M; Randolph C; Salloway S; Weiner M; Vellas B
    J Prev Alzheimers Dis; 2016; 3(2):68-74. PubMed ID: 29210442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.
    Ritchie CW; Molinuevo JL; Truyen L; Satlin A; Van der Geyten S; Lovestone S;
    Lancet Psychiatry; 2016 Feb; 3(2):179-86. PubMed ID: 26683239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
    Solomon A; Kivipelto M; Molinuevo JL; Tom B; Ritchie CW;
    BMJ Open; 2019 Feb; 8(12):e021017. PubMed ID: 30782589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.
    Aisen PS; Bateman RJ; Carrillo M; Doody R; Johnson K; Sims JR; Sperling R; Vellas B
    J Prev Alzheimers Dis; 2021; 8(3):306-312. PubMed ID: 34101788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research.
    Milne R; Bunnik E; Tromp K; Bemelmans S; Badger S; Gove D; Maman M; Schermer M; Truyen L; Brayne C; Richard E
    J Prev Alzheimers Dis; 2017; 4(2):125-131. PubMed ID: 29186282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
    Rafii MS; Sperling RA; Donohue MC; Zhou J; Roberts C; Irizarry MC; Dhadda S; Sethuraman G; Kramer LD; Swanson CJ; Li D; Krause S; Rissman RA; Walter S; Raman R; Johnson KA; Aisen PS
    Alzheimers Dement; 2023 Apr; 19(4):1227-1233. PubMed ID: 35971310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD).
    Walter S; Clanton TB; Langford OG; Rafii MS; Shaffer EJ; Grill JD; Jimenez-Maggiora GA; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):219-225. PubMed ID: 32920623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Souvenaid for Alzheimer's disease.
    Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
    Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
    Langbaum JB; Zissimopoulos J; Au R; Bose N; Edgar CJ; Ehrenberg E; Fillit H; Hill CV; Hughes L; Irizarry M; Kremen S; Lakdawalla D; Lynn N; Malzbender K; Maruyama T; Massett HA; Patel D; Peneva D; Reiman EM; Romero K; Routledge C; Weiner MW; Weninger S; Aisen PS
    Alzheimers Dement; 2023 Feb; 19(2):696-707. PubMed ID: 35946590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Neuroinformatics Framework for Canadian Consortium on Neurodegeneration in Aging (CCNA).
    Mohaddes Z; Das S; Abou-Haidar R; Safi-Harab M; Blader D; Callegaro J; Henri-Bellemare C; Tunteng JF; Evans L; Campbell T; Lo D; Morin PE; Whitehead V; Chertkow H; Evans AC
    Front Neuroinform; 2018; 12():85. PubMed ID: 30622468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Biomarker Outcomes into Clinical Trials for Alzheimer's Disease in Down Syndrome.
    Rafii MS; Zaman S; Handen BL
    J Prev Alzheimers Dis; 2021; 8(1):48-51. PubMed ID: 33336224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer's disease and other neuropsychiatric disorders.
    North H; Hofmann-Apitius M; Kas MJH; Marston H; Haas M
    Front Neurol; 2023; 14():1174079. PubMed ID: 37521302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.